Creative Biolabs-Immuno-oncology

Anti-CEA (clone MFE2E3) SynExpress E1-Cy3-TF2-X Modified CD8+ T cells (CAT#: ITS-1224-CR772)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CEA (clone MFE2E3). We employs the pGEM (EF1α-Cy3-TFIIB-XbaI) vector components and the SynExpress system of the Exons RNA Editing/Balancing feedback for a robust and sustained response against cancers.
Host
human
Target
CEA
Clone
MFE2E3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.87
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving